RDGT(Ridgetech, Inc.) 的财务报表:医疗保健,药品零售。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-03-31 | FY 截至 2023-03-31 | FY 截至 2024-03-31 | FY 截至 2025-03-31 | FY 截至 2026-03-31 |
|---|---|---|---|---|---|
| 营业收入 | $164.39M | $148.81M | $123.99M | $119.97M | $132.16M |
| 毛利润 | $36.52M | $3.60M | $4.88M | $3.84M | $4.75M |
| 营业利润 | −$2.69M | −$13.16M | $596.08K | −$1.04M | −$1.87M |
| 净利润 | −$3.19M | −$21.14M | −$4.23M | $10.19M | −$1.25M |
| 经营现金流 | −$5.39M | −$3.28M | −$3.16M | $1.25M | −$1.39M |
| 自由现金流 | −$5.48M | −$3.40M | −$3.49M | $1.09M | −$1.39M |
| 摊薄每股收益 | $-2752.50 | $-6219.00 | $-439.78 | $275.87 | $-17.21 |